PERFORMANCE BY THE NUMBERS: 2026 STATUS
98 % Reduction Target( by 2026) – AstraZeneca is targeting a 98 % absolute reduction in Scope 1 and 2 emissions by 2026, against a 2015 baseline, with residual emissions addressed through carbon removals.
77.5 % Achieved( as at end-2024 reporting) – The company reports a 77.5 % absolute reduction in operational( Scope 1 and 2) greenhouse gas emissions vs. 2015, demonstrating substantial progress toward its 2026 goal.
~ 20 % Energy Reduction( vs. 2015) – AstraZeneca reports a c. 20 % absolute reduction in total site energy consumption compared with 2015, exceeding its original 10 % reduction target.. 95 % Supplier Spend Target( by end- 2025) – By 2025, AstraZeneca aims for 95 % of purchased goods, services and capital goods spend to be with suppliers that have science-based targets aligned to 1.5 ° C pathways.
100 % Renewable Electricity( by end-2025) – The company has committed to sourcing 100 % renewable electricity across global operations by 2025.
This isn’ t merely about ticking boxes for compliance, it’ s a strategic co-investment in supplier capabilities that effectively raises the standard for the entire category The company has publicly committed investment to support the transition, signalling that sustainability is mission-critical rather than optional.
That supplier focus is already measurable. AstraZeneca reports strong progress on sustainable packaging and fleet electrification, and its supplier disclosure efforts have rapidly scaled. Procurement teams now track emissions intensity alongside traditional total
110 April 2026